Scleroderma in childhood a 35-year history of cases and review of the literature

Journal of Pediatric Orthopaedics

Volumn 20, Issue 4, 2000, Pages 442-449

  Bottoni, Craig R ^b   Reinker, Kent A ^a   Gardner, Richard D ^b   Person, Donald A ^b,c  

^a SHRINERS HOSPITALS FOR CHILDREN   (United States)

^b TRIPLER ARMY MEDICAL CENTER   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Connective tissue; En coup de sabre; Linear scleroderma; Morphea; Sclerodermaskin

Indexed keywords

ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC APPROACH ROUTE; DISEASE COURSE; FEMALE; HUMAN; JOINT CONTRACTURE; MALE; MORPHEA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCLERODERMA; SURGICAL TECHNIQUE; TREATMENT PLANNING;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; RETROSPECTIVE STUDIES; SCLERODERMA, SYSTEMIC; TREATMENT OUTCOME;

EID: 0033911168     PISSN: 02716798     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004694-200007000-00005     Document Type: Article

References (18)

1. Bernstein SM, Bernstein BH, Isaacson J. Scleroderma of the foot: orthopaedic treatment. Foot Ankle 1983;4:33-8.
2. Buckley SL, Skinner S, James P, Ashley RK. Focal scleroderma in children: an orthopaedic perspective. J Pediatr Orthop 1993;13: 784-90.
3. Christianson HB, Dorsey CS, O'Leary PA. Localized scleroderma: a clinical study of two hundred thirty-five cases. Arch Dermatol 1956;74:629-39.
4. Esterly NB, McKusick VA. Stiff skin syndrome. Pediatrics 1971; 47:360-9.
5. Eubanks LE, McBurney EI, Galen W, Reed R. Linear scleroderma in children. Int J Dermatol 1996;35:330-6.
6. Falanga V. Localized scleroderma. Med Clin North Am 1989;73: 1143-56.
7. Falanga V, Medsger TA Jr, Reichlin M, Rodnan GP. Linear scleroderma: clinical spectrum, prognosis, and laboratory abnormalities. Ann Intern Med 1986;104:849-57.
8. Joly P, Bamberger N, Crickx B, Belaich S. Treatment of severe forms of localized scleroderma with oral corticosteroids: follow-up study on 17 patients [Letter]. Arch Dermatol 1994;130:663-4.
9. Jordan RE. Immunologic diseases of the skin. Norwalk CT, San Mateo, CA: Appleton & Lange, 1991:394-6.
10. Kimball ES, Fisher MC. Potentiation of IL-1-induced BALB/3T3 fibroblast proliferation by neuropeptides. J Immunol 1988;141: 4203-8.
11. Kornreich HK, King KK, Bernstein BH, Singsen BH, Hanson V. Scleroderma in childhood. Arthritis Rheum 1977;20(suppl 2):343-50.
12. Krafchik BR. Localized cutaneous scleroderma. Semin Dermatol 1992;11:65-72.
13. Lever WF, Schaumburg-Ever G. Histopathology of the skin. Philadelphia: JB Lippincott, 1990:511-22.
14. Littman BH. Linear scleroderma: a response to neurologic injury: report and literature review. J Rheumatol 1989;16:1135-40.
15. Rubin L. Linear scleroderma: association with abnormalities of the spine and nervous system. Arch Dermatol Syph 1948;58:1-18.
16. Silverstein JL, Steen VD, Medsger TA Jr, Falanga V. Cutaneous hypoxia in patients with systemic sclerosis (scleroderma). Arch Dermatol 1988;124:1379-82.
17. Winkelmann RK, Kierland RR, Perry HD, Muller SA, Sams WM Jr. Management of scleroderma. Mayo Clin Proc 1971;46:128-34.
18. Yamanaka CT, Gibbs NF. Trauma: induced linear scleroderma. Cutis 1999;63:29-32.